SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematologic malignancies. Alloreactivity after HSCT is known to be mediated by adaptive immune cells expressing rearranging receptors. Recent studies demonstrated that the innate immune system could...

Descripción completa

Detalles Bibliográficos
Autores principales: Saliba, Rima M., Srour, Samer A., Greenbaum, Uri, Ma, Qing, Carmazzi, Yudith, Moller, Michael, Wood, Janet, Ciurea, Stefan O., Kongtim, Piyanuch, Rondon, Gabriela, Li, Dan, Saengboon, Supawee, Alousi, Amin M., Rezvani, Katayoun, Shpall, Elizabeth J., Cao, Kai, Champlin, Richard E., Zou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301275/
https://www.ncbi.nlm.nih.gov/pubmed/35874659
http://dx.doi.org/10.3389/fimmu.2022.904718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301275/
https://www.ncbi.nlm.nih.gov/pubmed/35874659
http://dx.doi.org/10.3389/fimmu.2022.904718

Ejemplares similares